Log in
Enquire now
Qed Therapeutics

Qed Therapeutics

Qed Therapeutics is a small Molecule Targeting Tyrosine Kinase Receptors founded in 2018.

OverviewStructured DataIssuesContributors

Contents

qedtx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Engineering
Engineering
Consumer biotechnology
Consumer biotechnology
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Healthcare
Healthcare
Pharmaceutical industry
Pharmaceutical industry
...
Location
San Francisco
San Francisco
Palo Alto, California
Palo Alto, California
CEO
Matt Outten
Matt Outten
0
Parent Organization
BridgeBio
BridgeBio
0
Founded Date
January 1, 2018
Country
United States
United States

Other attributes

Company Operating Status
Active
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Qed Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us